Atlanta’s QumulusAI began trading on Nasdaq under the ticker QMLS after a direct listing; the GPU‑cloud startup has booked big contracts but reported operating losses in recent years.

A Radiology study finds AI-generated X-rays can fool trained radiologists, creating new fraud and cybersecurity headaches for hospitals and insurers.

Brussels ordered Google to open Android and share anonymized search signals with rival AI firms, setting firm deadlines and raising privacy and legal questions. The move could reshape how assistants and search compete worldwide.

FIU scientists glycoengineered CAR‑T cells with a 'sugar shield' that helped them last longer and beat lymphomas in mice, pointing toward less‑toxic immunotherapy.

MGH and Dana‑Farber researchers built Aladynoulli, an AI trained on about 683,000 records that estimates risk for 348 conditions and could be tested inside hospital EHRs.

Tesseract Ventures has relocated its headquarters to Tampa and says it will ramp up local hiring as it prepares for a Series B funding round.

Eli Lilly agreed to buy AtaiBeckley for about $2.8B upfront, gaining an intranasal 5‑MeO‑DMT therapy now moving into Phase 3. The deal signals big‑pharma interest in rapid‑acting psychedelic treatments.

Greylock raised $1.5B for early‑stage AI startups while pledging a concentrated, hands‑on approach for founders in the Bay Area.

Anaconda has bought Kilo Code, folding an agentic engineering layer into its Austin‑based AI platform to give enterprises tighter control over model routing and token spend.

A Common Sense Media safety assessment says Google Search’s built‑in AI can mislead children and schools and parents lack an easy way to turn the feature off. Here’s what testers found and what to do next.

A Cambridge startup spun out of Toyota research revealed a $300M raise and a $1.1B valuation as it pushes humanoid machines into factory work.

La Jolla teams identified liver and tumor cholesterol pathways that point to new therapies, including a CTSA inhibitor that already cleared Phase 1 safety testing.

Anthro Energy's Proteus electrolyte could make batteries safer and denser. The Alameda startup has DOE and CEC backing as it prepares to scale.